Agritek Holdings Inc. (AGTK)

[jjr04001]

Friedman dropping bombs: Agritek Holdings, Inc. Completes Elimination of $850,000 of Toxic Debt From Former Lenders

LOS ANGELES, CA--(Marketwired - January 27, 2016) - Agritek Holdings, Inc. (OTC PINK: AGTK) (http://www.Agritekholdings.com), a leader in Compassionate Care Technology and agricultural solutions for the recreational cannabis industry, today announced the Company has eliminated and re-negotiated the removal of approximately $850,000 in toxic debt from two lenders on the Company's balance sheet. The negotiation also included new commitments to fund approximately $250,000 in new working capital, of which $87,500 has been funded, with new institutional lenders seeking a long term relationship with Agritek Holdings. The new lenders also purchased approximately $350,000 in aged notes from Tonaquint, Inc. and Vis Vires Group, Inc.

The above includes the recently announced retirement of $500,000 of toxic debt from the balance sheet in exchange for cash and interest in its' Nevada property. The Company expects to file an 8K next week regarding the engagement of a new auditing firm with the objective of becoming current in its reporting requirements.

"We have come too far over the last several years within the medicinal cannabis sector to give toxic lenders the ability to keep our common stock price at all time lows and continue conversions which have continued to have a dramatic effect and place downward pressure on not only the share price but completely putting a stranglehold on the Company while limiting resources. With a long term capital partner who has assured us their cooperation and belief in Agritek Holdings and new funding in place, I feel extremely confident that we can turn this Company into what it once was as a pioneer, the first fully reporting company in this sector and finally monetize our assets," stated B. Michael Friedman, CEO of Agritek Holdings Inc.

The Company will be communicating this week regarding the launch and licensing of our new CBD capsules CANNABOL Rx, containing the first patented flavored capsule and additional product lines in the weeks ahead.